Mouse Polyclonal WDR45 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human WDR45.
pH: 7.4
Constituents: 100% PBS
WB | ICC/IF | |
---|---|---|
Human | Tested | Tested |
Mouse | Predicted | Predicted |
Zebrafish | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Zebrafish | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 10 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Zebrafish | Dilution info - | Notes - |
Component of the autophagy machinery that controls the major intracellular degradation process by which cytoplasmic materials are packaged into autophagosomes and delivered to lysosomes for degradation (PubMed:23435086, PubMed:28561066). Binds phosphatidylinositol 3-phosphate (PtdIns3P) (PubMed:28561066). Activated by the STK11/AMPK signaling pathway upon starvation, WDR45 is involved in autophagosome assembly downstream of WIPI2, regulating the size of forming autophagosomes (PubMed:28561066). Together with WIPI1, promotes ATG2 (ATG2A or ATG2B)-mediated lipid transfer by enhancing ATG2-association with phosphatidylinositol 3-monophosphate (PI3P)-containing membranes (PubMed:31271352). Probably recruited to membranes through its PtdIns3P activity (PubMed:28561066).
WDRX1, WDRXI4, WIPI4, JM5, WDR45, WD repeat domain phosphoinositide-interacting protein 4, WIPI-4, WD repeat-containing protein 45
Mouse Polyclonal WDR45 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human WDR45.
pH: 7.4
Constituents: 100% PBS
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
The WDR45 protein also known as WD repeat domain phosphoinositide-interacting protein 4 (WIPI4) plays a necessary role in the autophagic process. It is a protein of approximately 42 kDa and consists of seven WD40 repeats which facilitate protein-protein interactions. The protein is broadly expressed in various tissues particularly in the brain. These interactions are critical in autophagy a process for degrading and recycling cellular components.
WDR45 contributes significantly to the regulation of autophagy. It acts as part of a multi-protein complex referred to as the autophagy-related 2 (ATG) complex. This complex is involved in autophagosome formation which is an important component in cellular degradation pathways. WDR45 binds phosphoinositides which are phospholipids integral to vesicle trafficking and membrane dynamics during autophagy.
The influence of WDR45 is evident in the PI3K/Akt signaling and AMPK signaling pathways. These pathways regulate cellular energy homeostasis and the response to metabolic stress. PI3K/Akt and AMPK modulate the activity of the mTOR pathway which is known to suppress autophagy. WDR45 interacts with other autophagy-related proteins such as LC3 and ULK1 facilitating the initiation of the autophagic process.
The connection to WDR45 is pronounced in neurodegenerative diseases like beta-propeller protein-associated neurodegeneration (BPAN) and Parkinson's disease. Mutations in WDR45 lead to defective autophagy resulting in the accumulation of damaged organelles and proteins in neurons. It is linked to proteins involved in these disorders such as PINK1 and Parkin further highlighting its potential role in disease pathology through impaired mitochondrial quality control and neural damage.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunofluorescence analysis of HeLa cells, labeling WDR45 with ab168532 at 10μg/ml.
All lanes: Western blot - Anti-WDR45 antibody (ab168532) at 1 µg/mL
Lane 1: WDR45 transfected 293T lysate at 15 µL
Lane 2: Non-transfected 293T lysate at 15 µL
Predicted band size: 39 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com